Search results
331 Results for 'Donald E. Ingber'
- Technologies (42)
- Collaborations (3)
- Team (0)
- News (213)
- Pages (0)
- Multimedia (55)
- Publications (0)
- Jobs (0)
- Events (18)
Technologies 42
-
AminoX: Making Better Protein Drugs, Quicker and Cheaper
AminoX enables protein drugs to only become active in the tumor microenvironment and not elsewhere in the body to avoid immune-related adverse effects in the body. By designing and building non-standard amino acids into strategic positions of protein drugs, AminoX provides tumor-specific, and longer-lasting target inhibition. -
Ichor: Reversing Aging
Ichor is addressing multiple age-related diseases by identifying genetic interventions that reprogram old cells to a younger state. Therapies based on these interventions could improve survival for cancer patients and long-term cardiovascular and neurological health. -
AquaPulse: Portable Off-the-Grid Water Purification
Globally, more than 2 billion people are forced to use a drinking water source that is contaminated with bacteria, parasites, and other pathogens, and an estimated 502,000 people die each year from diarrhea as a result of unsafe water. While a majority of the world has access to improved water sources, many are often contaminated;... -
Immunostimulatory RNA Therapeutic for Treatment of Cancer and Infectious Disease
Our novel dsRNAs stimulate the immune system to inhibit cancer, bacterial, and viral infections including SARS-CoV-2 and multiple influenza strains. -
eRapid: Multiplexed Electrochemical Sensors for Fast, Accurate, Portable Diagnostics
Handheld electrochemical sensors have revolutionized at-home medical testing for diabetics, but they have not yet been successfully applied to diagnosing other conditions. These sensors are based on the activity of an enzyme, and there are only a limited number of enzymes that can be used to detect biomarkers of human disease. An alternative, much more... -
Passive Directional Valve Technology: Towards More User-friendly and Accessible Microfluidic Devices for Diagnostic and Research Applications
Passive directional valves enable smaller and more complex microfluidics applications across of broad spectrum of future technologies, including diagnostics, drug development, and tissue engineering.
Collaborations 3
-
Brain Shuttle Research Sponsorship & Licensing
Enabling brain-targeted drug development through non-exclusive licensing and pre-competitive research sponsorship. -
Kraft Heinz Partnership
The Kraft Heinz company approached the Wyss Institute for help to achieve its ambitious goal to make its food products healthier, resulting in a novel technology that is ripe for commercialization. -
Wyss Brain Targeting Program
Advancing brain delivery approaches that enable more safe and effective brain-targeted therapeutics.
News 213
Multimedia 55
-
Audio/PodcastPlastic in our blood? That’s a problem. – Harvard ThinkingOur planet is filled with plastic. On average, we produce 430 million tons every year, most of which is used only for a short period of time and then discarded. But plastic isn’t just in the environment: it’s now in our bodies. Microplastics have been found in our bloodstreams, lungs, and other organs, and we’re... -
Video/AnimationAminoX: Making Better Protein Drugs, Quicker and CheaperA synthetic biology and advanced chemistry platform that efficiently incorporates non-standard amino acids by hacking the ubiquitous protein synthesis process. Credit: Wyss Institute at Harvard University -
Video/AnimationMice Don’t Menstruate: Reimagining Women’s Health Using Organ Chips with Dr. Donald IngberIn this episode, host Sharon Kedar, Co-Founder of Northpond Ventures, is joined by Dr. Donald Ingber, Founding Director at Wyss Institute for Biologically Inspired Engineering at Harvard University. Dr. Ingber’s commitment to following his passion has led him to countless medical and technological breakthroughs, including Organ Chip technology. These incredible chips recreate the structure and... -
Video/AnimationWhat is the future of Engineering with Bioengineering Pioneer Donald E Ingber – Museum of ScienceIs biological inspiration the key to the future of engineering? Bioethicist Insoo Hyun sits down with Donald E. Ingber, Founding Director of the Wyss Institute for Biologically Inspired Engineering and Professor of Bioengineering at Harvard’s School of Engineering & Applied Sciences. Together they explore the profound impact of Nature on engineering beyond the realms of... -
Video/AnimationWyss Institute: Past, Present, FuturePrior to the Wyss Institute’s founding in 2009, a working group at Harvard University assembled envision the future of biomedical engineering. Now in 2023, we see the how this foundation led to successful technologies positively impacting human and planet health. Credit: Wyss Institute at Harvard University -
Video/AnimationBridging science, engineering, and art: from mechanobiology to Human Organs-on-ChipsIn this Marsilius Lecture, Wyss Founding Director Don Ingber shares his personal path from a serendipitous experience in an undergraduate art class that led to his discovery of how living cells are constructed using “tensegrity” architecture and how this contributed to the birth of the field of Mechanobiology to his more recent work on human...
Events 18
-
Jun 22, 2023, 11:00am - 12:00pmWebinar
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Body-on-a-Chip technology is reshaping drug discovery, disease research, and personalized medicine. Please join a one-of-a-kind Ask Me Anything (AMA) session with the visionary behind it all: Donald Ingber. Prof. Ingber will be there, live, to answer YOUR questions and unveil the untapped potential of this groundbreaking technology. This is your chance to be part of... Free and open to public -
Mar 30, 2022, 1:00pm - 2:00pmWyss Event
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Endothelial cells (ECs) are a heterogeneous and ductile cell type that serves as a critical interface between blood and diverse tissue microenvironments. ECs can adopt brain organotypic properties in response to their interaction a complex ecosystem of cells: adjacent mural smooth muscle cells and pericytes, perivascular immune cells, and surrounding astrocytes that differ across brain... Free and open to public -
Mar 3, 2021, 11:00am - 3:00pmLecture
- Add to Calendar
- iCalendar
- Google Calendar
- Outlook
Biologic drugs comprise 40 percent of the current drug development pipeline. Existing in vitro and animal models are limited in their ability to evaluate the safety and efficacy of these drugs in humans. These limitations often result in development delays and increased costs. Organs-on-chips emulate human biology by providing a micro-engineered environment lined with living... Free and open to public